The number of entrants in the Chinese medicine formula granule market is increasing, and the market war is about to start

Traditional Chinese medicine formula granules are based on the reform and innovation of traditional Chinese medicine decoction pieces.
They are made by extracting and concentrating single Chinese medicine decoction pieces and are used for clinical formulating of Chinese medicine
.
They are used as a new series of Chinese medicine products to replace the decoction pieces of traditional Chinese medicine for clinical formula .
Since the "Interim Regulations on the Management of Chinese Medicine Formula Granules" was promulgated in 2001, the domestic Chinese medicine formula granule market has been in the pilot stage for a long time
.
At the national level, only 6 pilot manufacturing companies have been approved, including Jiangyin Tianjiang Pharmaceutical, China Resources Sanjiu Modern Chinese Medicine, Guangdong Yifang Pharmaceutical Co.
, Ltd.
, Sichuan New Green Pharmaceutical, Beijing Kangrentang Pharmaceutical, Nanning Peili Pharmaceutical, and they also So it occupies most of the market share
.
However, on November 1 this year, the State Food and Drug Administration and other departments ended the more than 20-year pilot work of traditional Chinese medicine formula granules and officially launched the registration module of traditional Chinese medicine formula granules.
The original market structure has begun to be broken and the industry has begun.
Usher in more changes
.
According to industry insiders, the end of the trial and the implementation of filing means first that the market is expected to expand rapidly, and the future market prospects of traditional Chinese medicine formula particles will be very worth looking forward to
.
Data shows that the current market size of traditional Chinese medicine formula granules has exceeded 50 billion, and many companies that deploy Chinese medicine formula granules have annual revenues of more than 1 billion yuan
.
After the country "opens up the Chinese medicine formula granules", the industry predicts that in the next few years, the market for Chinese medicine formula granules may exceed 100 billion yuan
.
It is worth noting that, in the face of the huge market blue ocean of traditional Chinese medicine formula particles, the number of entrants in the industry is also increasing, and the layout is constantly increasing
.
For example, in May of this year, Guoxin Tianjiang Pharmaceutical announced the commissioning of a production and processing base project for Chinese herbal medicine decoction pieces and dispensed granules
.
The project started construction in 2016.
The project covers an area of ​​189.
66 mu, with a total investment of 750 million yuan.
The first phase of the project has been completed, with an investment of more than 500 million yuan, a building area of ​​70,000 square meters, and a designed production capacity of 5,000 tons of decoction pieces per year.
3000 tons of Chinese medicine formula granules per year, the production scale and production capacity are among the forefront in North China
.
The project is expected to produce 1,049 tons of decoction pieces and formula granules of various types of Chinese medicine in the first year of production, with an output value of 238 million yuan. .
In June, Hongri Pharmaceutical also announced that it would invest 750 million yuan to build an intelligent manufacturing base of traditional Chinese medicine formula granules in Shandong, and the annual sales scale is expected to exceed 3 billion yuan
.
It is reported that this is the eighth Chinese medicine formula granule production base continuously constructed by Hongri Pharmaceutical in China
.
In addition to the above companies, according to incomplete statistics in the industry, there are currently more than 60 pharmaceutical companies that have obtained production qualifications approved by the State Food and Drug Administration
.
Among them, more than 30 listed pharmaceutical companies, including Xiangxue Pharmaceutical, Jinghua Pharmaceutical, Taiji Group, Jointown, etc.
, have deployed or clearly stated that they will deploy the traditional Chinese medicine formula granule industry
.
In addition, many listed plant extract companies have also planned their development plans in this field
.
The industry believes that with the increase of new entrants, for the Chinese medicine formula granule companies on the track, the future market competition will become more fierce, and at the same time, the company's supply chain capabilities will be further tested
.
It is understood that the traditional Chinese medicine formula granules generally need to go through the steps of Chinese medicine planting, decoction pieces production, granule production, and then to clinical adjustment.
In the case of fierce market competition, the company's supply chain capability is expected to become the key to future development
.